mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
1e-09 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-08 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
2e-08 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-08 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |